Item
(µM/ml) |
Control
n=20 |
All RA patients
n=94 |
Non-erosive
RA patients
n=18 |
Erosive
RA patients
n=45 |
NO2-ser |
1,30±0,11 |
2,46±0,33 |
1,76 ± 0,51 |
2,25 ± 0,42 |
NO3-ser |
1,17±0,08 |
1,13±0,24 |
0,86 ± 0,43 |
0,99 ± 0,22 |
NO-ser |
2,47±0,10 |
3,54±0,48* |
2,62 ± 0,79 |
3,24 ± 0,55 |
NO2-m |
1,12±0,31 |
9,19±1,25 |
6,42 ± 1,20* |
9,95 ± 2,33* |
NO3-m |
0,58±0,09 |
15,06±3,01 |
17,05 ± 4,16* |
17,97 ± 4,42* |
NO-m |
1,71±0,12 |
24,25±3,07* |
23,47 ± 4,76* |
27,92 ± 3,81* |
NO2-sin |
1,08±0,07 |
9,35±1,34* |
7,00 ± 0,93* |
8,20 ± 2,64* |
NO3-sin |
0,58±0,04 |
8,64±3,56 |
6,80 ± 1,20 |
18,03 ± 4,54* |
NO-sin |
1,66±0,11 |
17,99±3,41* |
13,80 ± 1,21* |
26,23 ± 3,78*◊ |
Note: n — number of patients in each group. * — differences from the control were significant at р<0.05 |